![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALNFL market cap is 17.5M. The company's latest EPS is EUR -0.3895 and P/E is -4.67.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 0 | 0 | 0 | 0 | 200k |
Operating Income | -347k | -318k | -902k | -3.08M | -4.23M |
Net Income | -267k | -261k | -978k | -2.44M | -3.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 467k | 577k | 3.69M | 2.4M | 3.97M |
Total Liabilities | 56k | 427k | 398k | 1.55M | 3.62M |
Total Equity | 411k | 150k | 3.29M | 844k | 350k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 17.5M |
Price to Earnings Ratio | -4.67 |
Price to Sales Ratio | 87.5 |
Price to Cash Ratio | 7.48 |
Price to Book Ratio | 49.99 |
Dividend Yield | - |
Shares Outstanding | 9.61M |
Average Volume (1 week) | 35.8k |
Average Volume (1 Month) | 20.12k |
52 Week Change | -17.08% |
52 Week High | 3.28 |
52 Week Low | 1.612 |
Spread (Intraday) | 0.02 (1.1%) |
Company Name | NFL Biosciences SA |
Address |
199 rue helene boucher castelnau-le-lez 34170 |
Website | https://www.nflbiosciences.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions